Ownership history in Robbins Farley · 13 quarters on record
This page tracks every 13F SEC filing in which Robbins Farley reported a position in Astrazeneca Plc Each Ads Representing 1/2 Of An Or (AZN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 49,906 | -4,243 | -7.8% | 2.08% | $4.6M | $181.96 |
| 2025 Q3 | ADDED | 54,149 | +27,582 | +103.8% | 1.73% | $4.2M | $151.86 |
| 2025 Q2 | ADDED | 26,567 | +26,167 | +6541.8% | 0.86% | $1.9M | $137.36 |
| 2023 Q3 | UNCHANGED | 400 | — | 0% | 0.02% | $27K | $128.47 |
| 2023 Q2 | UNCHANGED | 400 | — | 0% | 0.02% | $29K | $134.88 |
| 2023 Q1 | UNCHANGED | 400 | — | 0% | 0.02% | $28K | $130.81 |
| 2022 Q4 | UNCHANGED | 400 | — | 0% | 0.02% | $27K | $125.95 |
| 2022 Q3 | UNCHANGED | 400 | — | 0% | 0.02% | $22K | $101.88 |
| 2022 Q2 | UNCHANGED | 400 | — | 0% | 0.03% | $26K | $121.88 |
| 2021 Q4 | UNCHANGED | 400 | — | 0% | 0.02% | $23K | $105.70 |
As of 2025 Q4 — sorted by position size